Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway

Blood

Volumn 96, Issue 2, 2000, Pages 610-617

  Nomura, Keiko ^b   Kanegane, Hirokazu ^b   Karasuyama, Hajime ^b   Tsukada, Satoshi ^b   Agematsu, Kazunaga ^b   Murakami, Gyokei ^b   Sakazume, Satoru ^b   Sako, Masahiro ^b   Tanaka, Rieko ^b   Kuniya, Yoshinori ^b   Komeno, Takuya ^b   Ishihara, Shigehiko ^b   Hayashi, Keizo ^b   Kishimoto, Tadamitsu ^b   Miyawaki, Toshio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; INFANT; PRE B LYMPHOCYTE; PRIORITY JOURNAL; X LINKED AGAMMAGLOBULINEMIA;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; AGING; B-LYMPHOCYTES; BONE MARROW CELLS; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FLOW CYTOMETRY; HUMANS; INFANT; LINKAGE (GENETICS); LYMPHOCYTE COUNT; MUTATION; PROTEIN-TYROSINE KINASES; STEM CELLS; X CHROMOSOME;

EID: 0034662198     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Kincade PW. Formation of B lymphocytes in fetal and adult life. Adv Immunol. 1981;31:177-245.
2. Osmond DG. B cell development in the bone marrow. Semin Immunol. 1990;2:173-180.
3. Gathings WE, Lawton AR, Cooper MD. Immuno-fluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol. 1977;7:804-810.
4. Kamps WA, Cooper MD. Development of lymphocyte subpopulations identified by monoclonal antibodies in human fetuses. J Clin Immunol. 1984; 4:36-39.
5. Desiderio SV, Yancopoulos GD, Paskind M, et al. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature. 1984;311:752-755.
6. Nadler LM, Anderson KC, Marti G, et al. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol. 1983;131:244-250.
7. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow. II, Normal B lymphocyte development. Blood. 1987; 70:1316-1324.
8. Karasuyama H, Rolink A, Shinkai Y, Young F, Alt FW, Melchers F. The expression of VpreB/15 surrogate chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice. Cell. 1994;77:133-143.
9. Lassoued K, Nuñez CA, Phillips L, et al. Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell. 1993;73:73-76.
10. Guelpa-Fonlupt V, Tonelle C, Blaise D, Fougereau M, Fumoux F. Discrete early pro-B and pre-B stages in normal human bone marrow as defined by surface pseudo-light chain expression. Eur J Immunol. 1994;24:257-264.
11. Sakaguchi N, Melchers F. Lamda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes. Nature. 1986;324:579-582.
12. Hollis GF, Evans RJ, Stafford-Hollis JM, Korsmeyer SJ, McKearn JP. Immunoglobulin λ light-chain related genes 14.1 and 16.1 are expressed in pre-B cells and may encode the human immunoglobulin ω light-chain protein. Proc Natl Acad Sci U S A. 1989;86:5552-5556.
13. Kudo A, Melchers F. A second gene, VpreB in the λ5 locus, which appears to be selectively expressed in pre-B lymphocytes. EMBO J. 1987;6: 2267-2272.
14. Karasuyama H, Kudo A, Melchers F. The proteins encoded by the VpreB and λ5 pre-B specific genes can associate with each other and with μ heavy chain. J Exp Med 1990;172:969-972.
15. Tsubata T, Reth M. The products of pre-B cell specific genes (λ5 and VpreB) and immunoglobulin chain form a complex that is transported onto the cell surface. J Exp Med. 1990;172:973-976.
16. Kitamura D, Roes J, Kuhn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature. 1991;350:423-426.
17. Kitamura D, Kudo A, Schaal S, Muller W, Melchers F, Rajewsky K. A critical role of λS protein in B cell development. Cell. 1992;69:823-831.
18. Yel L, Minegishi Y, Coustan-Smith E, et al. Mutations in the mu heavy chain gene in patients with agammaglobulinemia. N Engl J Med. 1996;335: 1486-1493.
19. Minegishi Y, Coustan-Smith E, Wang Y-H, Cooper MD, Campana D, Conley ME. Mutations in the human λ5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med. 1998;187: 71-77.
20. Ghia P, ten Boekel E, Sanz E, de la Hera A, Rolink A, Melchers F. Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci. J Exp Med. 1996;184:2217-2229.
21. Wang Y-H, Nomura J, Faye-Petersen OM, Cooper MD. Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression. J Immunol. 1998;161: 1132-1139.
22. Tsuganezawa K, Kiyokawa N, Matsuo Y, et al. Flow cytometric diagnosis of the cell lineage and developmental stage of acute lymphoblastic leukemia by novel monoclonal antibodies specific to human pre-B-cell receptor. Blood. 1998;92:4317-4324.
23. Tsukada S, Saffran DC, Rawlings DJ, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993;72:279-290.
24. Vetrie D, Vorechovsky I, Sideras P, et al. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature. 1993;361:226-233.
25. Sideras P, Smith CIE. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol. 1995;59:135-223.
26. Conley ME, Cooper MD. Genetic basis of abnormal B cell development. Curr Opin Immunol. 1998;10:399-406.
27. Tsukada S, Rawlings DJ, Witte ON. Role of Bruton's tyrosine kinase in immunodeficiency. Curr Opin Immunol. 1994;6:623-630.
28. Vihinen M, Kwan SP, Lester T, et al. Mutations of the human BTK gene coding for Bruton tyrosine kinase in X-linked agammaglobulinemia. Hum Mutat. 1999;13:280-285.
29. Hashimoto S, Tsukada S, Matsushita M, et al. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood. 1996;88:561-573.
30. Gaspar HB, Lester T, Levinsky RJ, Kinnon C. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinemia (XLA): the use of protein analysis as a diagnostic Indicator of XLA. Clin Exp Immunol. 1998;111:334-338.
31. Futatani T, Miyawaki T, Tsukada S, et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood. 1998;91:595-602.
32. Hashimoto S, Miyawaki T, Futatani T, et al. Atypical X-linked agammaglobulinemia (XLA) diagnosed in adult. Internal Med. 1999;38:722-725.
33. Pearl ER, Vogler LB, Okos AJ, Crist WM, Lawton AR, Cooper MD. B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states. J Immunol. 1978;120:1169-1175.
34. Landreth KS, Engelhard D, Anasetti C, Kapoor N, Kincade PW, Good RA. Pre-B cells in agammaglobulinemia: evidence for disease heterogeneity among affected boys. J Clin Immunol. 1985;5:84-69.
35. Campana D, Farrant J, Inamdar N, Webster ADB, Janossy G. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol. 1990;145:1675-1680.
36. Milili M, Le Deist F, de Saint-Basile G, Fischer A, Fougereau M, Schiff C. Bone marrow cells in X-linked agammaglobulinemia express pre-B-specific genes (λ-like and V pre-B) and present immunoglobulin V-D-J gene usage strongly biased to a fetal-like repertoire. J Clin Invest. 1993;91: 1616-1629.
37. Mettre E, LeDeist F, de Saint-Basile G, et al. A non-XLA primary deficiency causes the earliest known defect of B cell differentiation in humans: a comparison with an XLA case. Immunol Lett. 1997;57:93-99.
38. Minegishi Y, Coustan-Smith E, Rapalus L, Ersoy F, Campana D, Conley ME. Mutations Igα (CD79a) result in a complete block in B-cell development. J Clin Invest. 1999;104:1115-1121.
39. Minegishi Y, Rohrer J, Coustan-Smith E, et al. An essential role for BLNK in human B cell development. Science. 1999;286:1954-1957.
40. H gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow. Blood. 1997;90:736-744.
41. Dworzak MN, Fritsch G, Froschl G, Printz D, Gadner H. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny. Blood. 1998;92:3203-3209.
42. Burrows PD, Cooper MD. B cell development and differentiation. Curr Opin Immunol. 1997;9:239-244.
43. Nuñez C, Nishimoto N, Gartland GL, et al. B cells are generated throughout life in humans. J Immunol. 1996;156:866-872.
44. Kurosaki T. Genetic analysis of B cell antigen receptor signaling. Ann Rev Immunol. 1999;17:555-592.
45. Conley ME. B cells in X-linked agammaglobulinemia. J Immunol. 1985;134:3070-3074.
46. Conley ME, Sweinberg SK. Females with a disorder phenotypically identical to X-linked agammaglobulinemia. J Clin Immunol. 1992;12:139-143.
47. Conley ME, Mathias D, Treadaway J, Minegishi Y, Rohrer J. Mutations in Btk in patients with presumed X-linked agammaglobulinemia. Am J Hum Genet. 1998;62:1034-1043.
48. Mensink EJ, Schuurman RK, Schot JD, Thompson A, Alt FW. Immunoglobulin heavy chain gene rearrangements in X-linked agammaglobulinemia. Eur J Immunol. 1986;16:963-967.
49. Levitt D, Ochs H, Wedgwood RJ. Epstein-Barr virus-induced lymphoblastoid cell lines derived from the peripheral blood of patients with X-linked agammaglobulinemia can secrete IgM. J Clin Immunol. 1984;4:143-150.
50. Anker R, Conley ME, Pollok BA. Clonal diversity in the B cell repertoire of patients with X-linked agammaglobulinemia. J Exp Med. 1989;169: 2109-2119.
51. Timmers E, Kenter M, Thompson A, et al. Diversity of immunoglobulin heavy chain gene segment rearrangement in B lymphoblastoid cell lines from X-linked agammaglobulinemia patients. Eur J Immunol. 1991;21:2355-2363.
52. Nonoyama S, Tsukada S, Yamadori T, et al. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia. J Immunol. 1998;161:3925-3929.
53. Bykowsky MJ, Haire RN, Ohta Y, et al. Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet 1996;58:477-483.
54. Kornfeld SJ, Haire RN, Strong SJ, et al. A novel mutation (Cys145-->Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51 -year-old male. Mol Med. 1996;2:619-623.
55. Rawlings DJ, Saffran DC, Tsukada S, et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993;261: 358-361.
56. Khan WN, Alt FW, Gerstein RM, et al. Defective B cell development and function in Btk-deficient mice. Immunity. 1995;3:283-299.
57. Kerner JD, Appleby MW, Mohr RN, et al. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity. 1995;3:301-312.
58. Conley ME, Parolini O, Rohler J, Campana D. X-linked agammaglobulinemia. Immunol Rev. 1994;138:5-21.